• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤性骨软化症。42例世界文献综述及2例新病例报告。

Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases.

作者信息

Ryan E A, Reiss E

出版信息

Am J Med. 1984 Sep;77(3):501-12. doi: 10.1016/0002-9343(84)90112-8.

DOI:10.1016/0002-9343(84)90112-8
PMID:6548080
Abstract

The clinical and biochemical data in 42 reported cases of oncogenous osteomalacia are reviewed, and data in two previously unreported cases are recorded. It is likely that the syndrome is more common than suggested by the paucity of reports and may account for a substantial fraction of nonfamilial, adult-onset "idiopathic" osteomalacia. Tumors associated with the syndrome are characteristically benign, of mesenchymal origin, highly vascular, and composed principally of giant and spindle cells. Complete excision of tumors results in cure of the osteomalacia in the majority of patients. The syndrome presumably represents an instance of humor-induced phosphaturia but supporting experimental data are scanty. Plasma levels of 1,25-dihydroxycholecalciferol are uniformly low, and treatment with this metabolite is generally very effective; however, abnormal vitamin D metabolism cannot by itself account for the syndrome.

摘要

回顾了42例报道的肿瘤性骨软化症病例的临床和生化数据,并记录了2例此前未报道病例的数据。该综合征可能比报道的罕见情况更为常见,可能是成人非家族性“特发性”骨软化症的重要组成部分。与该综合征相关的肿瘤通常为良性,起源于间充质,血管丰富,主要由巨细胞和梭形细胞组成。大多数患者肿瘤完全切除后骨软化症得以治愈。该综合征可能是体液性磷尿症的一个实例,但支持性实验数据较少。1,25 - 二羟胆钙化醇的血浆水平普遍较低,用这种代谢产物治疗通常非常有效;然而,维生素D代谢异常本身并不能解释该综合征。

相似文献

1
Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases.肿瘤性骨软化症。42例世界文献综述及2例新病例报告。
Am J Med. 1984 Sep;77(3):501-12. doi: 10.1016/0002-9343(84)90112-8.
2
Assessment of calcitriol and inorganic phosphate therapy before cure of oncogenous osteomalacia by resection of a mixed mesenchymal tumor.在通过切除混合性间叶肿瘤治愈肿瘤源性骨软化症之前,对骨化三醇和无机磷酸盐疗法的评估。
Bone. 1988;9(1):37-43. doi: 10.1016/8756-3282(88)90025-7.
3
Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone.1α,25 - 二羟胆钙化醇缺乏所致骨软化症。与骨巨细胞瘤的关联。
J Clin Invest. 1977 Nov;60(5):1046-53. doi: 10.1172/JCI108855.
4
Albright's syndrome associated with a soft-tissue myxoma and hypophosphataemic osteomalacia. Report of a case and review of the literature.
J Bone Joint Surg Br. 1983 Nov;65(5):621-6. doi: 10.1302/0301-620X.65B5.6315740.
5
Oncogenic osteomalacia associated with a mesenchymal chondrosarcoma.
Clin Invest Med. 1984;7(3):179-85.
6
Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.评估1,25-二羟维生素D3在X连锁低磷性佝偻病和骨软化症的发病机制及治疗中的作用。
J Clin Invest. 1980 Nov;66(5):1020-32. doi: 10.1172/JCI109930.
7
Cinacalcet in the management of tumor-induced osteomalacia.西那卡塞在肿瘤诱导性骨软化症治疗中的应用
J Bone Miner Res. 2007 Jun;22(6):931-7. doi: 10.1359/jbmr.070304.
8
[Effect of vitamin D metabolites on mineralization of bone tissue and phosphocalcium metabolism disorders in the course of vitamin D deficiency osteomalacia].
Rev Rhum Mal Osteoartic. 1978 Apr;45(4):241-8.
9
[Comparative evaluation of the effectiveness of vitamin D3 preparations (1-alpha-hydroxy- and 1-alpha,25-dihydroxycholecalciferol in various forms of osteoporosis and osteomalacia].[维生素D3制剂(1-α-羟基胆钙化醇和1-α,25-二羟基胆钙化醇)在各种形式骨质疏松症和骨软化症中的有效性比较评估]
Probl Endokrinol (Mosk). 1989 May-Jun;35(3):15-9.
10
Tumor induced osteomalacia.肿瘤诱导的骨软化症。
J Rheumatol. 1994 Jun;21(6):1162-4.

引用本文的文献

1
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.X连锁低磷血症诊断与管理的临床实践建议
Nat Rev Nephrol. 2025 May;21(5):330-354. doi: 10.1038/s41581-024-00926-x. Epub 2025 Jan 15.
2
PTH like substance secreting mesenchymal tumor causing oncogenic osteomalacia; unravelling the difficulties in localization - A report of 2 cases.分泌甲状旁腺激素样物质的间充质肿瘤导致致癌性骨软化症;解析定位难题——2例报告
J Orthop. 2024 Jun 26;58:123-127. doi: 10.1016/j.jor.2024.06.034. eCollection 2024 Dec.
3
Healthcare Resource Use Associated With Tumor-Induced Osteomalacia: A Literature Review.
与肿瘤诱导性骨软化症相关的医疗资源使用:文献综述
J Clin Endocrinol Metab. 2024 Dec 18;110(1):102-113. doi: 10.1210/clinem/dgae431.
4
Spinal phosphaturic mesenchymal tumors: a rare etiology causing tumor-induced osteomalacia-a review of experience at a UK tertiary referral center and literature review.脊柱磷酸盐尿性间叶性肿瘤:导致肿瘤性骨软化症的罕见病因——英国三级转诊中心的经验回顾和文献复习。
Eur Spine J. 2024 May;33(5):1911-1920. doi: 10.1007/s00586-023-08031-6. Epub 2023 Nov 14.
5
Phosphaturic Mesenchymal Tumors with or without Phosphate Metabolism Derangements.伴或不伴磷酸盐代谢紊乱的磷酸盐尿性间叶性肿瘤。
Curr Oncol. 2023 Aug 8;30(8):7478-7488. doi: 10.3390/curroncol30080541.
6
Sphenoid sinus is a rare site for tumor-induced osteomalacia: A case report and literature review.蝶窦是肿瘤诱导性骨软化罕见的发病部位:病例报告及文献复习。
Front Endocrinol (Lausanne). 2023 Mar 24;14:1116793. doi: 10.3389/fendo.2023.1116793. eCollection 2023.
7
A diagnostic challenge of mysterious bone pain caused by tumor-induced osteomalacia with multiple tumors: a case report.肿瘤诱导性骨软化症合并多发肿瘤所致神秘骨痛的诊断挑战:一例报告
Transl Cancer Res. 2023 Feb 28;12(2):413-420. doi: 10.21037/tcr-22-2116. Epub 2023 Feb 3.
8
Hypophosphatemic osteomalacia in neurofibromatosis 1 associated with intracranial gliomas and congenital renal agenesis: A rare case report and review of the literature.1型神经纤维瘤病伴颅内胶质瘤和先天性肾发育不全的低磷性骨软化症:1例罕见病例报告并文献复习
J Orthop Case Rep. 2022 Feb;12(2):23-29. doi: 10.13107/jocr.2022.v12.i02.2650.
9
Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases.肿瘤相关性骨软化症:895 例的系统临床综述。
Calcif Tissue Int. 2022 Oct;111(4):367-379. doi: 10.1007/s00223-022-01005-8. Epub 2022 Jul 20.
10
Current Aspects on the Pathophysiology of Bone Metabolic Defects during Progression of Scoliosis in Neurofibromatosis Type 1.1型神经纤维瘤病脊柱侧弯进展过程中骨代谢缺陷的病理生理学现状
J Clin Med. 2022 Jan 15;11(2):444. doi: 10.3390/jcm11020444.